Ces heatmaps interactifs comparent les profils de tolérabilité des médicaments. En sélectionnant les effets indésirables à éviter, vous visualisez et comparez les médicaments entre eux.
Données issues de récentes méta-analyses en réseau et de lignes directrices cliniques.
Bientôt disponibles pour une utilisation clinique.
Projet de recherche clinique en cours.
Contactez tngominh@cpac-apcc.org pour en savoir plus.
These interactive heatmaps compare the tolerability profiles of medications. By selecting the side effects you wish to avoid, you can visualize how medications compare to one another.
Data sourced from recent network meta-analyses and guidelines.
Coming soon for routine clinical use.
Ongoing clinical research project.
Reach tngominh@cpac-apcc.org for more information.
to be updated *add metabolic parameters*
to be translated in English
Huhn M, et al., Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019 Sep 14;394(10202):939-951.
Pillinger T, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jan;7(1):64-77.
Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024;69(5):297–312.
De Crescenzo F et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170-184.